Lazard Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Sell
21,826
-278
-1% -$13.6K ﹤0.01% 1281
2025
Q1
$1.12M Sell
22,104
-23,543
-52% -$1.2M ﹤0.01% 1179
2024
Q4
$2.06M Buy
45,647
+34,069
+294% +$1.54M ﹤0.01% 872
2024
Q3
$428K Sell
11,578
-7,082
-38% -$262K ﹤0.01% 1405
2024
Q2
$568K Buy
18,660
+12,156
+187% +$370K ﹤0.01% 1158
2024
Q1
$188K Buy
6,504
+4,741
+269% +$137K ﹤0.01% 1317
2023
Q4
$47K Sell
1,763
-3,637
-67% -$97K ﹤0.01% 1904
2023
Q3
$120K Buy
5,400
+1,063
+25% +$23.6K ﹤0.01% 1562
2023
Q2
$175K Buy
4,337
+3,017
+229% +$122K ﹤0.01% 1383
2023
Q1
$63K Sell
1,320
-1,158
-47% -$55.3K ﹤0.01% 1722
2022
Q4
$94K Buy
2,478
+1,326
+115% +$50.3K ﹤0.01% 1554
2022
Q3
$57K Buy
+1,152
New +$57K ﹤0.01% 1741
2022
Q2
Sell
-25,192
Closed -$939K 2543
2022
Q1
$939K Buy
25,192
+23,250
+1,197% +$867K ﹤0.01% 1009
2021
Q4
$77K Buy
+1,942
New +$77K ﹤0.01% 1543
2021
Q3
Sell
-282
Closed -$11K 2263
2021
Q2
$11K Sell
282
-2,931
-91% -$114K ﹤0.01% 1895
2021
Q1
$152K Sell
3,213
-6,821
-68% -$323K ﹤0.01% 1143
2020
Q4
$612K Buy
+10,034
New +$612K ﹤0.01% 950
2020
Q2
Sell
-1,580
Closed -$70K 1758
2020
Q1
$70K Buy
+1,580
New +$70K ﹤0.01% 1081
2019
Q4
Sell
-346
Closed -$11K 1639
2019
Q3
$11K Buy
+346
New +$11K ﹤0.01% 1294
2016
Q1
Sell
-9,275
Closed -$300K 1094
2015
Q4
$300K Sell
9,275
-6,234
-40% -$202K ﹤0.01% 769
2015
Q3
$414K Buy
+15,509
New +$414K ﹤0.01% 718